NASDAQ:GHSI - Guardion Health Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.59 +0.03 (+1.17 %)
(As of 04/21/2019 04:00 PM ET)
Previous Close$2.59
Today's Range$2.25 - $2.77
52-Week Range$2.25 - $4.00
Volume44,353 shs
Average Volume53,947 shs
Market Capitalization$56.77 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Guardion Health Sciences, Inc., a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Vision Testing Diagnostics segment develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. Its products include VectorVision CSV-1000, an instrument for contrast sensitivity testing; and ESV-3000 ETDRS, a device for early treatment diabetic retinopathy study in visual acuity testing. The company distributes its products through direct sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Receive GHSI News and Ratings via Email

Sign-up to receive the latest news and ratings for GHSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GHSI
CUSIPN/A
CIKN/A
Phone858-605-9055

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees19
Market Cap$56.77 million
Next Earnings DateN/A
OptionableNot Optionable

Guardion Health Sciences (NASDAQ:GHSI) Frequently Asked Questions

What is Guardion Health Sciences' stock symbol?

Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI."

Has Guardion Health Sciences been receiving favorable news coverage?

Media coverage about GHSI stock has trended neutral this week, according to InfoTrie. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Guardion Health Sciences earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.

Who are some of Guardion Health Sciences' key competitors?

Who are Guardion Health Sciences' key executives?

Guardion Health Sciences' management team includes the folowing people:
  • Mr. Michael Favish, Pres, CEO & Chairman (Age 70)
  • Mr. John W. Townsend, Controller & Chief Accounting Officer (Age 57)
  • Dr. David W. Evans, Chief Science Officer & Director (Age 63)
  • Mr. Vincent J. Roth, Gen. Counsel & Corp. Sec. (Age 51)

When did Guardion Health Sciences IPO?

(GHSI) raised $6 million in an initial public offering on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

When does Guardion Health Sciences' quiet period expire?

Guardion Health Sciences' quiet period expires on Wednesday, May 15th. Guardion Health Sciences had issued 1,250,000 shares in its initial public offering on April 5th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During Guardion Health Sciences' quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Guardion Health Sciences' stock price today?

One share of GHSI stock can currently be purchased for approximately $2.59.

How big of a company is Guardion Health Sciences?

Guardion Health Sciences has a market capitalization of $56.77 million. Guardion Health Sciences employs 19 workers across the globe.

What is Guardion Health Sciences' official website?

The official website for Guardion Health Sciences is http://www.guardionhealth.com.

How can I contact Guardion Health Sciences?

Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The company can be reached via phone at 858-605-9055 or via email at [email protected]


MarketBeat Community Rating for Guardion Health Sciences (NASDAQ GHSI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  1 (Vote Outperform)
Underperform Votes:  1 (Vote Underperform)
Total Votes:  2
MarketBeat's community ratings are surveys of what our community members think about Guardion Health Sciences and other stocks. Vote "Outperform" if you believe GHSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GHSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/21/2019 by MarketBeat.com Staff

Featured Article: Net Asset Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel